ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
Where to invest $20,000 in ASX 200 shares
Share Market News
Why I would buy Telstra and these ASX blue chip shares
Growth Shares
These blue chip ASX shares could give your portfolio a big lift in July
Growth Shares
Why I would buy Altium and these ASX growth shares
Growth Shares
Where to invest $10,000 in ASX 200 shares in July
Share Market News
Leading brokers name 3 ASX shares to sell today
Share Gainers
What you need to know about the surge in Pargagon Care's share price
⏸️ Best ASX Shares
Top ASX stock picks for July
⏸️ Best ASX Shares
Why these 2 ASX large-cap shares are my favourites for the long-term
Growth Shares
3 top ASX growth shares to buy in July
⏸️ ASX Shares
These 2 shares are focused on healthy long-term growth
Share Market News
Bring your portfolio to life with these quality ASX 200 healthcare shares
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
